Stay updated on SL-401 Combo With Pomalid/Dex in MM Clinical Trial
Sign up to get notified when there's something new on the SL-401 Combo With Pomalid/Dex in MM Clinical Trial page.

Latest updates to the SL-401 Combo With Pomalid/Dex in MM Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed on the page. This is a metadata update and does not alter study details, eligibility criteria, or other user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded the Multiple myeloma topic and consolidated the Locations section (California, Massachusetts, Oregon) with a revision from v3.3.2 to v3.3.3.SummaryDifference0.6%

- Check31 days agoChange DetectedRemoved the page topic label 'Multiple myeloma' and the 'MedlinePlus Genetics' related topics from the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check45 days agoChange DetectedRelated topics were added to the page, including Multiple myeloma and a MedlinePlus Genetics link. These appear in the related topics section to provide quick access to background resources.SummaryDifference0.2%

- Check52 days agoChange DetectedRevision: v3.3.2 is now displayed and related topics such as 'Multiple myeloma' and 'MedlinePlus Genetics' were removed, along with the previous 'Revision: v3.2.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check59 days agoChange DetectedThe government funding/operating status notice has been removed from the page, while all study details remain unchanged.SummaryDifference0.4%

Stay in the know with updates to SL-401 Combo With Pomalid/Dex in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SL-401 Combo With Pomalid/Dex in MM Clinical Trial page.